Timothy Carroll to Natalizumab
This is a "connection" page, showing publications Timothy Carroll has written about Natalizumab.
Connection Strength
0.171
-
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment. PLoS One. 2018; 13(12):e0209326.
Score: 0.171
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.